Explore Donald E. Ingber net worth, age, height, bio, birthday, wiki, and salary! In this article, we will discover how old is Donald E. Ingber? Who is Donald E. Ingber dating now & how much money does Donald E. Ingber have?
Donald E. Ingber Biography
Donald E. Ingber is one of the most popular and richest Biologist who was born on May 1, 1956 in East Meadow, New York, United States.
Ingber grew up in East Meadow, New York. He received a combined B.A./M.A. in molecular biophysics and biochemistry from Yale College and Yale Graduate School of Arts and Sciences in 1977; an M.Phil. in cell biology from Yale Graduate School of Arts and Sciences in 1981; and a combined M.D./Ph.D. from Yale School of Medicine and Yale Graduate School of Arts and Sciences in 1984. At Yale, he carried out undergraduate research on DNA repair with Paul Howard-Flanders, and on cancer metastasis with Alan Sartorelli.
Ingber’s work on tensegrity led him to propose that mechanical forces play as important a role in biological control as chemicals and genes do, and to investigate the molecular mechanism by which cells convert mechanical signals into changes in intracellular biochemistry and gene expression, a process known as “mechanotransduction.” Ingber determined that living cells use tensegrity architecture to stabilize their shape and cytoskeleton, that cellular integrins function as mechanosensors on the cell surface, and that cytoskeletal tension (or “prestress,” which is central to the stability of tensegrity structures) is a fundamental regulator of many cellular responses to mechanical cues. Ingber’s tensegrity theory also led to the prediction in the early 1980s that changes in extracellular matrix structure and mechanics play a fundamental role in tissue and organ development, and that deregulation of this form of developmental control can promote cancer formation.
| Name | Donald E. Ingber |
| First Name | Donna |
| Last Name | Hartley |
| Occupation | Biologist |
| Birthday | May 1 |
| Birth Year | 1956 |
| Place of Birth | East Meadow |
| Home Town | New York |
| Birth Country | United States |
| Birth Sign | Taurus |
| Full/Birth Name | |
| Father | Not Available |
| Mother | Not Available |
| Siblings | Not Available |
| Spouse | Not Known |
| Children(s) | Not Available |
Ethnicity, religion & political views
Many peoples want to know what is Donald E. Ingber ethnicity, nationality, Ancestry & Race? Let's check it out! As per public resource, IMDb & Wikipedia, Donald E. Ingber's ethnicity is Not Known. We will update Donald E. Ingber's religion & political views in this article. Please check the article again after few days.
Ingber has also been named to multiple Who’s Who lists for his diverse contributions including: Science and Engineering (1991), America (1994), the World (1997), Medicine and Healthcare (1999), Business Leaders and Professionals—Honors Edition (2007), and was honored with the Albert Nelson Marquis Lifetime Achievement Award in 2018.
Donald E. Ingber Net Worth
Donald E. Ingber is one of the richest Biologist from United States. According to our analysis, Wikipedia, Forbes & Business Insider, Donald E. Ingber's net worth $5 Million. (Last Update: December 11, 2023)
Donald E. Ingber (born 1956) is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering, the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences.
| Net Worth | $5 Million |
| Salary | Under Review |
| Source of Income | Biologist |
| Cars | Not Available |
| House | Living in own house. |
In 2009, Ingber was named Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, which was launched with a $125 million gift— which at the time was the largest philanthropic gift in Harvard’s history—from Swiss philanthropist and entrepreneur Hansjörg Wyss. The Wyss Institute was founded to enable high-risk research and disruptive innovation, and to catalyze the field of biologically inspired engineering in which newly uncovered biological design principles are leveraged to develop new engineering innovations in the form of bioinspired materials and devices for medicine, industry, and the environment. The Institute is a partnership among Harvard University, its major affiliated hospitals (Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Boston Children’s Hospital, Dana Farber Cancer Institute, Massachusetts General Hospital, Spaulding Rehabilitation Hospital), Boston University, Massachusetts Institute of Technology, Tufts University, University of Massachusetts Medical School, Charité – Universitätsmedizin Berlin, and University of Zurich.
One of his more recent innovations is the creation of tiny, complex, three-dimensional models of living human organs, known as “organs-on-chips” (Organ Chips), which mimic complicated human organ functions in vitro as a way to potentially replace traditional animal-based methods for testing of drugs and toxins. The first human Organ Chip, a human Lung Chip, was reported in Science in 2010. Created using microchip manufacturing methods, the Lung Chip is a complex three-dimensional model of a breathing lung that incorporates living human lung alveolar epithelial cells interfaced with endothelial cells within microfluidic channels cast in silicone rubber, which recapitulate structure and function of the tissue-vasculature interface of lung alveolus (air sacs). In 2012, Ingber and his team demonstrated in a study in Science Translational Medicine the ability to mimic a complex human disease on the Lung Chip — specifically pulmonary edema, known commonly as “fluid on the lungs” — and to identify new therapeutics using this model. As an alternative to animal studies, Organ Chips could be used to study the safety and efficacy of new drugs, accelerating the introduction of new drugs to market while significantly lowering research costs. Ingber’s group has since expanded this technology to develop other model organs, including the intestine, kidney, bone marrow, blood-brain barrier, and liver. In 2012, Ingber’s team was awarded a DARPA contract to string together multiple Organ Chips to build an automated human body-on-chips that will recapitulate whole-body physiology. This system could be used in combination with computational modeling to rapidly assess responses to new drug candidates, providing critical information on their safety, efficacy, and pharmacokinetics.
Height, Weight & Body Measurements
Donald E. Ingber height Not available right now. Donna weight Not Known & body measurements will update soon.
| Height | Unknown |
| Weight | Not Known |
| Body Measurements | Under Review |
| Eye Color | Not Available |
| Hair Color | Not Available |
| Feet/Shoe Size | Not Available |
Ingber worked on development of cancer therapeutics with Kenneth Harrap at the Royal Cancer Hospital/Royal Marsden Hospital in England, with support from a Bates Traveling Fellowship. He carried out his Ph.D. dissertation research under the direction of Dr. James Jamieson in the department of cell biology, and his advisory committee included George Palade, Elizabeth Hay and Joseph Madri. From 1984 to 1986 he completed his training as an Anna Fuller Postdoctoral Fellow under the mentorship of Dr. Judah Folkman in the Surgical Research Laboratory at Boston Children’s Hospital and Harvard Medical School.
Other new technologies from Ingber’s lab include development of a fully biodegradable plastic alternative inspired by natural cuticle material found in shrimp shells and insect exoskeletons, known as “Shrilk”; a mechanically activated nanotherapeutic that selectively directs clot-busting drugs to sites of vascular occlusion while minimizing unintended bleeding; an siRNA nanoparticle therapy that prevents breast cancer progression; a dialysis-like sepsis device that cleanses blood of all infectious pathogens, fungi and toxins without requiring prior identification; a surface coating for medical materials and devices that prevents clot formation and bacteria accumulation that reduces the need for use of conventional anticoagulant drugs that frequently result in life-threatening side effects, and a computational approach to diagnostics and therapeutics that incorporates both animation and molecular modeling software to virtually develop and test potential drugs designed to fit precisely into their targets’ molecular structures.
Who is Donald E. Ingber Dating?
According to our records, Donald E. Ingber is possibily single & has not been previously engaged. As of December 1, 2023, Donald E. Ingber’s is not dating anyone.
Relationships Record: We have no records of past relationships for Donald E. Ingber. You may help us to build the dating records for Donald E. Ingber!Ingber also has served as a consultant to numerous companies in the pharmaceutical, biotechnology, and cosmetics industries, including Merck, Roche, Astrazeneca, Biogen, Chanel, and L’Oreal, among others. He currently chairs the Scientific Advisory Boards of Emulate, Inc. and Boa Biomedical, Inc.
Facts & Trivia
Donna Ranked on the list of most popular Biologist. Also ranked in the elit list of famous people born in United States. Donald E. Ingber celebrates birthday on May 1 of every year.
You may read full biography about Donald E. Ingber from Wikipedia.ncG1vNJzZmiZnKGzornOrqqboaKptaWt2GeaqKVfmbyvrcudZJ5lmaO0o7HRaA%3D%3D